Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ali Eshaghpour"'
Autor:
Daniel Tham, Lucy Zhao, Wenhui Yu, Jayhan Kherani, Roger Kou, Allen Li, Pei Ye Li, Ali Eshaghpour, Mark Andrew Crowther
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 8, Iss 7, Pp 102584- (2024)
Background: Direct oral anticoagulants (DOACs) have emerged as the first-line therapy for venous thromboembolism and stroke prophylaxis in atrial fibrillation. As DOACs are partially excreted renally, their safety in patients with chronic kidney dise
Externí odkaz:
https://doaj.org/article/b3c67d2eca2d420bab0b817216992118
Autor:
Lucy Zhao, Daniel Tham, Wendy Yu, Jayhan Kherani, Allen LI, Pei Ye LI, Ali Eshaghpour, Mark Crowther
Publikováno v:
HemaSphere, Vol 7, p e974141e (2023)
Externí odkaz:
https://doaj.org/article/0d4db29f03e54eff9943c181e2c1a691
Publikováno v:
HemaSphere, Vol 7, p e1167638 (2023)
Externí odkaz:
https://doaj.org/article/d7c47023ef994fdda51dd4a342b16bb8
Autor:
Wenhui Yu, Jayhan Kherani, Lucy Zhao, Daniel Tham, Allen LI, Harry LI, Ali Eshaghpour, Mark Crowther
Publikováno v:
HemaSphere, Vol 7, p e200448c (2023)
Externí odkaz:
https://doaj.org/article/2c60bdf393d0446aaf9c00e34f68aef6
Autor:
Lucy Zhao, Jayhan Kherani, Pei Ye LI, Kevin Zhang, Angelina Horta, Christine Lin, Allen LI, Ali Eshaghpour, Mark Crowther
Publikováno v:
HemaSphere, Vol 7, p e8567529 (2023)
Externí odkaz:
https://doaj.org/article/e790d887582041efb12c2fdc78768ac2
P1665: USE OF DOACS IN THE MANAGEMENT OF UPPER EXTREMITY DEEP VENOUS THROMBOSIS; A SYSTEMATIC REVIEW
Publikováno v:
HemaSphere, Vol 7, p e2856211 (2023)
Externí odkaz:
https://doaj.org/article/ebebee90c3db4160aea0128bf81c3f0e
Publikováno v:
HemaSphere, Vol 7, p e0223224 (2023)
Externí odkaz:
https://doaj.org/article/8e8034a5a1b24c90a5aa67d0f7e10dfc
Publikováno v:
European Journal of Haematology. 109:166-181
Effective treatments for hematologic malignancies include therapies that target tyrosine kinase (TK) signaling pathways. Tumor lysis syndrome (TLS) is an oncologic emergency that can occur due to rapid turnover following the initiation of treatments
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2528cac89f4fd1dcb6e2b0397328967c
https://doi.org/10.1111/ejh.13786
https://doi.org/10.1111/ejh.13786
Background: Outcome measures in randomized controlled trials (RCTs) can be classified as patient-important, surrogate and composite outcomes. Venous thromboembolism (VTE) prophylaxis trials often use surrogate or composite outcome measures, often inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fee080394fee31d325d11bd37d66225a
https://doi.org/10.21203/rs.3.rs-1582705/v1
https://doi.org/10.21203/rs.3.rs-1582705/v1
Autor:
Eric Tseng, Maria Tiboni, Ali Eshaghpour, Rick Ikesaka, Mehran Anvari, Mark Crowther, James D. Douketis, Allen Li, Deborah M. Siegal
Publikováno v:
Thrombosis Research. 198:1-6
Introduction Bariatric surgery patients experience an increased risk of venous thromboembolism (VTE), however, the optimal dose of low-molecular-weight heparin for VTE prophylaxis remains uncertain. Currently, St. Joseph's Healthcare Hamilton utilize
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9055b61d76125025b626b25dcf16dea
https://doi.org/10.1016/j.thromres.2020.11.021
https://doi.org/10.1016/j.thromres.2020.11.021